StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
SVB Leerink Downgrades bluebird bio (BLUE) to Market Perform, Following Earnings, Business Update
August 9, 2021 12:45 PM
SVB Leerink analyst Mani Foroohar downgraded bluebird bio (NASDAQ: BLUE) from ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Downgrades
Next Articles
bluebird bio (BLUE) PT Lowered to $19 at Morgan Stanley
August 11, 2021 8:26 AM
Goldman Sachs Downgrades bluebird bio (BLUE) to Neutral
August 10, 2021 6:56 AM
bluebird bio (BLUE) PT Lowered to $18 at Stifel
August 9, 2021 1:56 PM